A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety of a New 6:2 Influenza Virus Reassortant.
Phase of Trial: Phase IV
Latest Information Update: 14 Jun 2011
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors MedImmune
- 15 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jun 2010 Actual initiation date (Jun 2010) added as reported by ClinicalTrials.gov.